Evidence map›Paper›PMID 35337033›Full record

ArticleViruses2022

SARS-CoV-2 and Influenza Virus Co-Infection Cases Identified through ILI/SARI Sentinel Surveillance: A Pan-India Report.

Neeraj Aggarwal, Varsha Potdar, Neetu Vijay, Labanya Mukhopadhyay, Biswajyoti Borkakoty, S Manjusree, Manohar Lal Choudhary, Deepika Chowdhury, Riya Verma, Sumit Dutt Bhardwaj and 4 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 3 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 3 syntheses or guidelines pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Neeraj AggarwalVirology Unit, Division of Epidemiology and Communicable Diseases, Indian Council of Medical Research, New Delhi 110029, India.ORCID 0000-0003-3139-2994
Varsha PotdarNational Institute of Virology, Pune 411001, India.
Neetu VijayVirology Unit, Division of Epidemiology and Communicable Diseases, Indian Council of Medical Research, New Delhi 110029, India.ORCID 0000-0002-9066-9132
Labanya MukhopadhyayVirology Unit, Division of Epidemiology and Communicable Diseases, Indian Council of Medical Research, New Delhi 110029, India.ORCID 0000-0002-0721-0161
Biswajyoti BorkakotyRegional Medical Research Center, Dibrugarh 786010, India.
S ManjusreeVirus Research and Diagnostic Laboratory, Government Medical College, Thiruvananthapuram 695011, India.
Manohar Lal ChoudharyNational Institute of Virology, Pune 411001, India.ORCID 0000-0001-9968-8957
Deepika ChowdhuryNational Institute of Virology, Pune 411001, India.
Riya VermaNational Institute of Virology, Pune 411001, India.
Sumit Dutt BhardwajNational Institute of Virology, Pune 411001, India.
Neelanjana SarmahRegional Medical Research Center, Dibrugarh 786010, India.
Sreelatha K HVirus Research and Diagnostic Laboratory, Government Medical College, Thiruvananthapuram 695011, India.
Prabhat KumarDivision of Biomedical Informatics, Indian Council of Medical Research, New Delhi 110029, India.
Nivedita GuptaVirology Unit, Division of Epidemiology and Communicable Diseases, Indian Council of Medical Research, New Delhi 110029, India.
ICMR-National Institute of Virology · INIndian Council of Medical Research · INGovernment Medical College · INRegional Medical Research Center · IN

Funding

Department of Health Research, India R.15013/01/2021-HR/VRDL
6 · The paper itself

Abstract

SARS-CoV-2/influenza virus co-infection studies have focused on hospitalized patients who usually had grave sequelae. Here, we report SARS-CoV-2/influenza virus co-infection cases from both community and hospital settings reported through integrated ILI/SARI (Influenza Like Illness/Severe Acute Respiratory Infection) sentinel surveillance established by the Indian Council of Medical Research. We describe the disease progression and outcomes in these cases. Out of 13,467 samples tested from 4 July 2021-31 January 2022, only 5 (0.04%) were of SARS-CoV-2/influenza virus co-infection from 3 different sites in distinct geographic regions. Of these, three patients with extremes of age required hospital admission, but none required ICU admission or mechanical ventilation. No mortality was reported. The other two co-infection cases from community settings were managed at home. This is the first report on SARS-CoV-2/Influenza virus co-infection from community as well as hospital settings in India and shows that influenza viruses are circulating in the community even during COVID-19. The results emphasize the need for continuous surveillance for multiple respiratory pathogens for effective public health management of ILI/SARI cases in line with the WHO (World Health Organization) recommendations.

Indexed as

CoinfectionCOVID-19Influenza, HumanOrthomyxoviridaeHumansSARS-CoV-2SeasonsSentinel Surveillanceco-infectionCOVID-19influenzaSARS-CoV-2surveillance

Identifiers

PMID35337033
PMCPMC8954151
OpenAlexW4221062503

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.